Chronic wounds and growth factors;Chronische wunden und wachstumsfaktoren

H+G Zeitschrift fur Hautkrankheiten

Volumn 74, Issue 11, 1999, Pages 664-672

  Scharffetter Kochanek, K ^a   Meewes, Ch ^a   Eming, S ^a   Dissemond, J ^a   Hani, N ^a   Wenk, J ^a   Wlaschek, M ^a   Brenneisen, P ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Chronic ulcers; Chronic wounds; Growth factors; Wound healing

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PLATELET DERIVED GROWTH FACTOR BB; RECOMBINANT GROWTH FACTOR;

DIABETES MELLITUS; DRUG APPROVAL; DRUG EFFICACY; HUMAN; LEG ULCER; REVIEW; SURGICAL APPROACH; TOPICAL DRUG ADMINISTRATION; TREATMENT INDICATION; WOUND HEALING;

EID: 0032730274     PISSN: 03010481     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Arblaster G. (1998): Pressure sore incidence: a strategy for reduction. Nursing Standard 12, 49-54.
2. Atn S C., Misra J., Bisht D, et al. (1990): Use of homologous platelet factors in achieving total healing of recalcitrant skin ulcers. Surgery 108, 508.
3. Bennett N. T. and Schultz G S. (1993): Growth factors and wound healing: part II role in normal and chronic wound healing. Am J Surg 166, 74-81.
4. Brown G. L. Curtsinger L, Jurkiewicz M. J. et al. (1991): Stimulation of healing of chronic wounds by epidermal growth factor. Plast Reconstr Surg 88, 189-196.
5. Brown G. L., Nanney L. B., Griffen J. et al (1989): Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med 321, 76-79.
6. Chantry D., Turner M., Abney E. et al. (1989): Modulation of cytokine production by transforming growth factor-beta. J Immunol 142, 4295-4300.
7. Clark R A. and Hansen P M (1988) The molecular and cellular biology of wound repair New York (Plenum Press)
8. Cohen I. K , Crossland M C., Garrett A. et al. (1995) Topical application of epidermal growth factor onto partial-thickness wounds in human volunteers does not enhance reepithelialization. Plast Reconstr Surg 96, 251-254
9. Cox D. A., Kunz S , Cerletti N. et al. (1992): Wound healling in aged animals, effect of locally applied TGF-besa 2 in different model systems In Angiogenesis-Key Principles (Eds Steiner R , Weisz P B., Langer R.), Birkhauser, Basel, 287-295
10. Czaja M. R., Weiner F. R. Eghbali M. et al. (1987): Differential effects of g-interferon on collagen and fibronectin gene expression. J Biol Chem 262, 13348-13351
11. Eckes B., Scharffetter-Kochanek K., Wlaschek M. et al (1997): Connective tissue regulation in tissue repair and fibrosis Curr Opin Derm 4, 276-281.
12. Eming S. A., Lee J., Snow R. G. et al. (1995): Genetically modified human epidermis overexpressing PDGF-A directs the development of a cellular and vascular connective tissue stroma when transplanted to athymic mice - implications for the use of genetically modified keratinocytes to modulate dermal regeneration. J Invest Dermatol 105, 756-763.
13. Falanga V. and Eaglstein W. H. (1993). The "trap" hypothesis of venous ulceration. Lancet 341, 1006-1008.
14. Flour M. and Degreef H. (1998): Pharmalogical treatment of wounds. Sem Cutan Med Surg 17, 260-265
15. Glaser B. M., Michels R. G., Kuppermann B. D. et al. (1992): Transforming growth factor-beta 2 for the treatment of full thickness macular holes. Ophthalmology 99, 1162-1173.
16. Grinnell F. and Zhu M. (1996): Fibronectin degradation in chronic wounds depends on the relative levels of elastase, alpha 1-proteinase inhibitor, and alpha 2-macroglobulin. J Invest Dermatol 106, 335-341.
17. Grotendorst G. R., Martin G. R., Pencev D. et al. (1985): Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. J Clin Invest 76, 2323-2329.
18. Hayward P., Hokanson J., Heggers J. et al. (1992): Fibroblast growth factor reverses the bacterial retardation of wound contraction. Am J Surg 163, 288-293.
19. Holloway G. A , Steed D. L., DeMarco M. J. et al. (1993): A randomized, controlled multicenter, dose response trial of activated platelet supernatant, topicola CT-102 in chronic, nonhealing. diabetic wounds Wounds 5, 198.
20. Ignotz R. A. and Massague J. (1986): Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261, 4337-4345.
21. Kintsy C P. and Lynch S E. (1393): Role of growth factors in cutaneous wound healing, a review. Critic Rev Oral Biol Med 4, 729-760.
22. Knighton D R., Ciresi D., Fiegel V. D. et al. (1990): Stimulation of repair in chronic non-healing cutaneous ulcers using platelet-derived wound healing formula. Surgery 170, 56-60.
23. Knighton D. R., Fiegel V D., Austin L. L et al. (1986): Classification and treatment of chronic nonhealing wounds. Sucessful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg 204, 322-330.
24. Knighton D R., Phillips G. D., Fiegel V D, (1990) Wound healing angiogenesis: indirect stimulation by basic fibroblast growth factor. J Trauma 30, S134-S144.
25. Konturek P. C., Konturek S. J., Brzozowski T. et al. (1995): Epidermal growth factor and transforming growth factor-alpha; role in protection and healing of gastric mucosal lesions. Eur J Gastroenterol Hepatol 7, 933-938.
26. Krupski W. C , Reilly L. M Perez S. et al. (1991) A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds, a preliminary report. J Vasc Surg 14, 526-536.
27. Kulozik M , Heckmann M., Mauch C et al. (1991): Cytokine regulation of collagen metabolism during wound healing in vitro and in vivo. In: Wound Healing Janssen H, Rooman R, Robertson JIS (eds). Wrightson Biomedical Publishing LTD. Petersfield, pp 33-41.
28. Lawrence T. and Diegelmann R. F. (1994): Growth factors in wound healing. Clinics Dermatol 12, 157-169
29. LeGrand E (1998): Preclinical promise of Becaplermin (rhPDGF-BB) in wound healing. Am J Surg 176, 48S-54S
30. Malik I A , Zahid M., Haq S et al. (1998). Effect of subcutaneous injection of granulocyte-macrophage colony stimulating factor (GM-CSF) on healing of chronic refractory wounds. Eur J Surg 164, 737-744
31. Marques da Costa, Jesus F. M., Anicieto C. et al. (1997). Double-blind randomized placebo-controlled trial of the use of granulocyte-macrophage colony-stimulating factor in chronic leg ulcers. Am J Surg 173, 165-168.
32. Martin P (1997): Wound healing - aiming for perfect skin regeneration. Science 276, 75-81.
33. Massagué J. (1996): TGF-beta signalling: receptors, transducers and mad proteins. Cell 85, 947-950.
34. Mauch C., Oono T., Eckes B. et al. (1993): The biology of granulation tissue. In: Dermatology -Progress & Perspectives. Burgdorf WHC, Katz SI (eds), The Parthenon Publishing Group, pp 986-988.
35. Meyer-Ingold W. (1993): Wound therapy: growth factors as agents to promote healing. Tibtech 11, 387-392.
36. Meyer-Ingold W. and Eichner W. (1995): Platelet-derived growth factor. Cell Biol Int 19, 389-398.
37. Mustoe T. A., Cutler N. R., Allman R. M. et al. (1994): A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers. Arch Surg 129, 213-219.
38. Mustoe T. A., Pierce G F., Thomason A. et al. (1987): Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science 237, 1333-1336
39. Nath C and Gulati S. C. (1998): Role of cytokines in healing chronic skin wounds. Acta Haematol 99, 175-179.
40. Nwohmeh B C., Yager D. R., Cohen I. K. (1998): Physiology of the chronic wound. Clin Plast Surg 25, 341-356
41. O'Kane S. and Ferguson M. W. (1997): Transforming growth, factor-betas and wound healing. Int J Biochem Cell Biol 29, 63-78.
42. Okumura K., Kiyohara Y., Komada F et al. (1990): Improvement in wound healing by epidermal growth factor (EGF) ointment: 1. effect of Nafamostat, Gabexate, or Gelatin on stabilization and efficacy of EGF Pharmaceutical Res 7, 1289-1293.
43. Peus D , Jungtaubl H., Knaub S. et al. (1995): Localization of platelet-derived-growth factor receptor subunit expression in chronic venous leg ulcers. Wound Rep Regen 3: 265-272.
44. Pierce P. F., Tarpley J. E., Yangihara D. et al. (1992): Platelet-derived growth factor (BB heterodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Am J Pathol 140, 1375-1388.
45. Postlethwaite A. E., Keski-Oja J., Moses H. L. (1987): Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor-beta. J Exp Med 165, 251-256
46. Rao C. N., Ladin D. A., Liu Y Y. et al. (1995). Alpha 1-antitrypsin is degraded and non-functional in chronic wounds but intact and functional in acute wounds' the inhibitor protects fibronectin from degradation by chronic wound fluid enzymes. J Invest Dermatol 105, 572-578
47. Regan M C. and Barbul A. (1991): Regulation of wound healing by the T cell-dependent immune system In: Wound healing (Eds. Janssen H. Rooman R. Robertson JIS). Petersfield, Wrightson Biomedical Publishing LTD, 21-31
48. Reiber G E. et al. (1996): The epidemiology of diabetic foot problems. Diabet Med 13, 6-11
49. Roberts A B (1996): Transforming growth factor beta activity and efficacy in animal models of wound healing Wound Rep Reg 3, 408-418.
50. Robson M. C Mustoe T. A., Hunt T. K (1998): The future of recombinant growth factors in wound healing. Am J Surg 176, 80S-82S
51. Robson M. C , Phillips L. G., Lawrence W. T et al. (1992): The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores. Ann Surg 216, 401-408.
52. Robson M. C , Phillips L. G , Thomason A. et al. (1992): Platelet-derived growth factor BB for the treatment of chronic pressure ulcers Lancet 339, 23-25
53. Robson M C., Phillips L. G., Thomason A. et al. (1992): Recombinant human platelet-derived growth factor-BB for the treatment of chronic pressure ulcers. Ann Plast Surg 29, 193-201.
54. Rotaton D. S., Caffee H. H., Copeland F. M. et al. (1990): Surg Forum 41, 627-630.
55. Rothe M and Falanga V. (1989): Growth factors. Arch Dermatol 125, 1390-1398.
56. Sabolinski M. L. Alvarez O., Auletta M. et al. (1996): Cultured skin as a smart material for healing wounds: experiences in chronic wounds. Biomaterial 17, 311-320.
57. Scharffetter K., Kulozik M., Stolz W. et al. (1989): Localization of collagen alpha1(1) gene expression during wound healing by in situ hybridization. J Invest Dermatol 93: 405-412.
58. Scharffetter-Kochanek K., Klein P., Krieg T. (1998): Cellular and molecular mechanisms of tissue repair. Basic Res Cardiol 93: S1-3.
59. Scharffetter-Kochanek K., Wlaschek M. (1995): Wundheilung und Bindegewebe. In: Entzündung Grundlagen - Klinik - Therapie. Dargel R (Hrsg). Ullstein Mosby Verlag, Berlin, Wiesbaden.
60. Schultz G., Bennett N , Rotaton S. et al. (1993): EGF and TGF-alpha in wound healing: analysis of wound fluids and effects of exogenous factors on wound healing. J Cell Biochem 17E, 109.
61. Sporn M B., Roberts A. B., Shull J H. et al. (1983): Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. Science 219, 1329-1330.
62. Stanley A. C , Park H Y., Phillips T. J. et al. (1997): Reduced growth of dermal fibroblasts from chronic venous ulcers can be stimulated with growth factors. J Vasc Surg 26, 994-1001
63. Steed D. L. and the Diabetic Ulcer Study Group (1995). Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. J Vasc Surg 21, 71-81
64. Steed D L., Goslen J B., Holloway G A. et al. (1992): Randomized prospective double-blind trial in healing chronic diabetic foot ulcers Diabetes Care 15, 1598-1604.
65. Stoschek C. M., Nanney L. B., King L. E (1992): Quantitative determination of EGF-R during epidermal wound healing. J Invest Dermatol 99, 645-649.
66. Vogt P. M., Lehnhardt M., Wagner D. et al. (1998): Determination of endogenous growth factors in human wound fluid: temporal presence and profiles of secretion. Plast Reconstr Surg 102, 117.
67. Vogt P. M., Peter F. W., Topsakal E. et al. (1998): Zum Einsatz von Wachstumsfaktoren in der Therapie chronischer Wunden. Chirurg 69, 1197-1206.
68. Weiss S. J. (1989): Tissue destruction by neutrophils In: Mechanisms of disease. N Engl J Med (Epstein FH, ed.), 365-376.
69. Werner S. (1998). Cytokine Growth Factor Rev 9, 153-165.
70. Wieman T. S., Smiell J. M., Su Y. (1998): Efficacy and safety of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with nonhealing lower extremity diabetic ulcer: a phase III randomized, double blind study. Diabet Care 21, 821-827.
71. Wilkins L. M., Watson S. R., Prosky S. E. et al. (1994): Development of a bilayered living skin construct for clinical applications. Biotechnol Bioengineer 43, 747-756.
72. Wlaschek, M., Achterberg V., Meyer-Ingold W. et al. (1997): Protease inhibitor protect growth factor activity in chronic wounds Br J Dermatol 137: 646.
73. Yager D. R., Chen S. M., Ward S. I. et al. (1997): Ability of chronic wound fluids to degrade peptide growth factors associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Rep Reg 5, 23-32.